AI assistant
Sending…
Merck & Co., Inc. — Director's Dealing 2010
Nov 18, 2010
284_dirs_2010-11-18_ee4739c4-e88a-4c01-a2f1-8a7ebc850053.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Merck & Co. Inc. (MRK)
CIK: 0000310158
Period of Report: 2010-11-17
Reporting Person: REPRESAS CARLOS E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-11-17 | Common Stock | M | 1666.0000 | $24.3000 | Acquired | 3166.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-11-17 | Stock Option (right to buy) | $24.3000 | M | 1666.0000 | Disposed | 2019-04-30 | Common Stock (1666.0000) | Direct |
Footnotes
F1: The option vests in three equal annual installments beginning May 1, 2010.
More from Merck & Co., Inc.
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 4
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 8
Proxy Solicitation & Information Statement
2026
Apr 8